Boston Scientific Corporation
BSX
Rang în acțiuni
#409
Această descriere a companiei este disponibilă doar în limba engleză.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Preț acțiune
$41.88
Ultima sincronizare: 2026-10-30
Capitalizare de piață
$60.69B
Variație (1 zi)
-1.89%
Variație (1 an)
-58.42%
Țară
US
Date bursiere: Financial Modeling Prep·Actualizat la ·Nu este un sfat de investiții·Cum calculăm
Tranzacționează Boston Scientific Corporation (BSX)
Categorie
Healthcare
EPS pentru Boston Scientific Corporation (BSX)
EPS la data de September 2026 TTM: $2.37
Conform celor mai recente rapoarte financiare și prețului acțiunilor Boston Scientific Corporation, EPS-ul actual al companiei (TTM) este $2.37. La sfârșitul anului 2025, compania avea un EPS de $1.96 o creștere față de EPS-ului din 2024, care a fost de $1.26.
Istoricul EPS pentru Boston Scientific Corporation din 2000 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Variație |
|---|---|---|
| 2026 (TTM) | $2.37 | 20.92% |
| 2025 | $1.96 | 55.56% |
| 2024 | $1.26 | 16.61% |
| 2023 | $1.08 | 140.75% |
| 2022 | $0.45 | -35.19% |
| 2021 | $0.69 | -952.83% |
| 2020 | $-0.08 | -102.40% |
| 2019 | $3.38 | 179.14% |
| 2018 | $1.21 | 1,412.50% |
| 2017 | $0.08 | -69.23% |
| 2016 | $0.26 | -244.44% |
| 2015 | $-0.18 | 100.00% |
| 2014 | $-0.09 | 0.00% |
| 2013 | $-0.09 | -96.89% |
| 2012 | $-2.89 | -1,096.55% |
| 2011 | $0.29 | -141.43% |
| 2010 | $-0.70 | 2.94% |
| 2009 | $-0.68 | -50.00% |
| 2008 | $-1.36 | 312.12% |
| 2007 | $-0.33 | -88.26% |
| 2006 | $-2.81 | -469.74% |
| 2005 | $0.76 | -40.16% |
| 2004 | $1.27 | 122.81% |
| 2003 | $0.57 | 23.91% |
| 2002 | $0.46 | -807.69% |
| 2001 | $-0.07 | -114.13% |
| 2000 | $0.46 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $2.70 | 13.92% |
US
|
|
| $4.09 | 72.57% |
IE
|
|
| $9.45 | 298.73% |
US
|
|
| $2.21 | -6.84% |
DE
|
|
| $1.74 | -26.58% |
US
|
Întrebări despre profitul pe acțiune Boston Scientific Corporation
Cât este profitul pe acțiune Boston Scientific Corporation?
Conform celor mai recente date (sept. 2026), profitul pe acțiune Boston Scientific Corporation pe ultimele 12 luni este de $2.37.
Cât a fost profitul pe acțiune Boston Scientific Corporation în 2025?
În 2025, profitul pe acțiune Boston Scientific Corporation a fost de $1.96, în creștere cu 55.56% față de 2024 ($1.26).
Cum a evoluat profitul pe acțiune Boston Scientific Corporation din 2020 încoace?
Între 2020 și 2025, profitul pe acțiune Boston Scientific Corporation a atins maximul în 2025 ($1.96) și minimul în 2020 ($-0.08).
Cum se situează profitul pe acțiune Boston Scientific Corporation față de companiile similare?
Cu $2.37, profitul pe acțiune Boston Scientific Corporation este mai mare decât la 2 dintre companiile similare din lista de mai sus (5 în total). Dintre acestea, cea mai mare valoare o are Stryker Corporation ($9.45).